Effect of amantadine on L-2-14C-dopa metabolism in parkinsonism.
D000284:Administration, Oral; D000368:Aged; D000547:Amantadine / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D002264:Carboxylic Acids / Q000097:blood / Q000652:urine; D002395:Catecholamines / Q000097:blood / Q000652:urine; D002852:Chromatography, Ion Exchange; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000097:blood* / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000097:blood*; D010636:Phenols / Q000097:blood / Q000652:urine; D013997:Time Factors
D002250:Carbon Radioisotopes; D002264:Carboxylic Acids; D002395:Catecholamines; D010636:Phenols; D004295:Dihydroxyphenylalanine; D000547:Amantadine